Cargando…
GPER-1 acts as a tumor suppressor in ovarian cancer
BACKGROUND: It is known that the new membrane-bound estrogen receptor GPER-1 acts suppressive in breast cancer cells and its expression decreases during disease progression. This study was conducted to evaluate the GPER-1 expression in ovarian cancer and its correlation with progression. Its functio...
Autores principales: | Ignatov, Tanja, Modl, Saskia, Thulig, Maike, Weißenborn, Christine, Treeck, Oliver, Ortmann, Olaf, Zenclussen, AC, Costa, Serban Dan, Kalinski, Thomas, Ignatov, Atanas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723961/ https://www.ncbi.nlm.nih.gov/pubmed/23849542 http://dx.doi.org/10.1186/1757-2215-6-51 |
Ejemplares similares
-
Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020) -
Mast Cells Retard Tumor Growth in Ovarian Cancer: Insights from a Mouse Model
por: Meyer, Nicole, et al.
Publicado: (2023) -
B Cells Induce Early-Onset Maternal Inflammation to Protect against LPS-Induced Fetal Rejection
por: Uehre, Gina Marie, et al.
Publicado: (2023) -
Icb-1 gene polymorphism rs1467465 is associated with susceptibility to ovarian cancer
por: Schüler, Susanne, et al.
Publicado: (2014) -
Impact of cavity shaving on residual tumor rates in patients with primary invasive carcinoma and carcinoma in situ in breast conserving surgery
por: Fernández-Pacheco, Miriam, et al.
Publicado: (2022)